Aubry, P; Warnick, LD; Guard, CL; Hill, BW and Witt, MF (2001). Health and performance of young dairy calves vaccinated with a modified live Mannheimia haemolytica and Pasteurella multocida vaccine. J. Am. Vet. Med. Assoc., 219: 1739-1742.
Ayalew, S; Confer, AW; Payton, ME; Garrels, KD; Shrestha, B; Ingram, KR; Montelongo, MA and Taylor, JD (2008). Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin. Vaccine. 26: 4955-4961.
Batra, SA; Shanthalingam, S; Donofrio, G and Srikumaran, S (2016). A chimeric protein comprising the immunogenic domains of
Mannheimia haemolytica leukotoxin and outer membrane protein PlpE induces antibodies against leukotoxin and PlpE. Vet. Immunol. Immunopathol.,
175: 36-41.
Carpenter, T; Khalid, S and Sansom, MS (2007). A multi domain outer membrane protein from Pasteurella multocida: modelling and simulation studies of PmOmpA. Biochim. Biophys. Acta. 1768: 2831-2840.
Clinkenbeard, KD; Mosier, DA and Confer, AW (1989). Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infect. Immun., 57: 420-425.
Confer, AW and Ayalew, S (2018).
Mannheimia haemolytica in bovine respiratory disease: immunogens, potential immunogens, and vaccines. Anim. Health Res. Rev., 19: 79-99.
Confer, AW; Ayalew, S; Panciera, RJ; Montelongo, M and Wray, JH (2006). Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine. 24: 2248-2255.
Confer, AW; McCraw, RD; Durham, JA; Morton, RJ and Panciera, RJ (1995). Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1. Vet. Immunol. Immunopathol., 47: 101-110.
Conlon, JA; Shewen, PE and Lo, RY (1991). Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1. Infect. Immun., 59: 587-591.
Gatto, NT; Dabo, SM; Hancock, RE and Confer, AW (2002). Characterization of, and immune responses of mice to, the purified OmpA-equivalent outer membrane protein of Pasteurella multocida serotype A:3 (Omp28). Vet. Microbiol., 87: 221-235.
Guzman-Brambila, C; Quintero-Fabian, S; Gonzalez-Castillo, C; de Obeso-Fernandez del Valle, A; Flores-Samaniego, B; de la Mora, G; Rojas-Mayorquin, AE and Ortuno-Sahagun, D (2012). LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge. Res. Vet. Sci., 93: 1293-1300.
Hsuan, SL; Kannan, MS; Jeyaseelan, S; Prakash, YS; Malazdrewich, C; Abrahamsen, MS; Sieck, GC and Maheswaran, SK (1999). Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-kappaB activation and calcium elevation. Microb. Pathogenesis. 26: 263-273.
Lee, HY; Kehrli Jr, ME; Brogden, KA; Gallup, JM and Ackermann, MR (2000). Influence of beta(2)-integrin adhesion molecule expression and pulmonary infection with Pasteurella haemolytica on cytokine gene expression in cattle. Infect. Immun., 68: 4274-4281.
Maheswaran, SK; Weiss, DJ; Kannan, MS; Townsend, EL; Reddy, K; Rwhiteley, LO and Srikumaran, S (1992). Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Vet. Immunol. Immunop., 33: 51-68.
Morton, RJ; Panciera, RJ; Fulton, RW; Frank, GH; Ewing, SA; Homer, JT and Confer, AW (1995). Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure. Am. J. Vet. Res., 56: 875-879.
Ozbey, G and Muz, A (2006). Isolation of aerobic bacteria from the lungs of chickens showing respiratory disorders and confirmation of Pasteurella multocida by polymerase chain reaction (PCR). Vet. Arh., 76: 217-225.
Pandher, K; Confer, AW and Murphy, GL (1998). Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1. Infect. Immun., 66: 5613-5619.
Pandher, K; Murphy, GL and Confer, AW (1999). Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1. Vet. Microbiol., 65: 215-226.
Purdy, CW; Straus, DC; Sutherland, RJ and Ayres, JR (1996). Efficacy of a subcutaneously administered, ultraviolet light-killed Pasteurella haemolytica A1-containing vaccine against transthoracic challenge exposure in goats. Am. J. Vet. Res., 57: 1168-1174.
Quinn, PJ; Markey, BK; Leonard, FC; Hartigan, P; Fanning, S and Patrick, ESF (2011). Veterinary microbiology and microbial disease. UK, John Willy & Son Ltd.
Rajeev, S; Kania, SA; Nair, RV; McPherson, JT; Moore, RN and Bemis, DA (2001). Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment. Vaccine. 19: 4842-4850.
Shewen, PE; Lee, CW; Perets, A; Hodgins, DC; Baldwin, K and Lo, RY (2003). Efficacy of recombinant sialoglycoprotease in protection of cattle against pneumonic challenge with Mannheimia (Pasteurella) haemolytica A1. Vaccine. 21: 1901-1906.
Shewen, PE and Wilkie, BN (1985). Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am. J. Vet. Res., 46: 1212-1214.
Yektaseresht, A; Sabet Sarvestani, F; Dordani, M and Hosseini, A (2019). Cloning and expression of Mannheimia haemolytica PlpE gene in Escherichia coli and its immunogenicity assessment. Arch. Razi Inst., 74: 111-118.
)